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Abstract : To determine the influence of
circulatory factors on recovery from
neuromuscular block, we measured train of
four (TOF) response in the arm with
tourniquet inflated during TOF = 0.1 and
compared this with data from a control arm in
40 patients under fentanyl-propofol-nitrous
oxide-isoflurane anaesthesia. Patients were
allocated randomly to receive either
atracurium 0.5 mg/kg (n=20) or vecuronium
0.1 mg/kg (n=20). The TOF response of ulnar
nerve in both arms was recorded in every 12
sec. When neuromuscular block was 90%
(TOF = 0.1), the tourniquet was inflated to a
pressure of 300 mmHg, and when a
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Introduction
The onset of neuromuscular block is determined by
the rate at which blocker molecules reach the
neuromuscular junction and this, in turn, is thought to
depend to a large extent on circulatory factors, which
influence the interval between injection of the drug in a
peripheral vein and its arrival at the neuromuscular
junction (1, 2). Cardiac output has been recognised as a
factor modifying the onset time of depolarizing and
nondepolarizing agents (3, 4). In humans, the role of
muscle blood flow is likely to explain the faster onset with
respiratory muscles than with peripheral muscles.
If muscle blood flow were the only determinant of
onset time, interruption of circulation to the muscle
would be expected to affect intensity of paralysis, and the
block should remain constant in a muscle without blood
supply. The application of a tourniquet to interrupt blood
flow has been used during recovery after systemic
injection of atracurium. In spite of the lack of circulation
in the arm, recovery was found to continue more slowly
in the isolated than in the perfused arm. This finding was
explained by Hoffman degradation and ester hydrolysis in
the non perfused arm (5, 6).
The purpose of this study was to measure the onset
of nevromuscular block in an arm with a tourniquet

neuromuscular block recovery of 75% was
reached, the block recovery time in both
perfused and tourniquet arms was
determined.
The
recorvery
from
neuromuscular block was markedly delayed in
the tourniquet arms in both groups (p<0.01).
As the recorvery time was longer in the
vecuronium group than in atracurium group,
we suggest the use of vecuronium in the
microsurgery of the isolated extremities.
Key
Words:
Neuromuscular
block,
atracurium, vecuronium, measurement of
response.

inflated during onset, compared with a normally perfused
arm. To determine if the results depended on the
mechanism of the action of the blocker used, we studied
two groups of patients, one receiving vecuronium and the
other atracurium (7, 8).
Patients and Methods
After obtaining approval from the Hospital Research
Etchics Committee, we studied 40 ASA I-II adult patients
undergoing orthopedic and gynaecological surgery who
were between 20-55 years of age. Patients had no renal,
hepatic or neuromuscular disease and were not receiving
any drug. Patients were allocated randomly to one of two
drugs: group I to systemic atracurium 0.5 mg/kg, and
group 2 to systemic vecuronium 0.1 mg/kg.
Patients received atropine 0.01 mg/kg IM and
pethidine 1 mg/kg IM as premedication, 1 hour before
surgery. On arrival in the operating room, a 20 gauge IV
cannula was inserted into a dorsal hand vein. ECG, pulse
oximetry, capnometry and arterial pressure were
monitored noninvasively. A tourniquet cuff was placed
around the right arm. Surface electrodes were applied
near the ulnar nerve at both wrists. The
electromyographic response was recorded with a FischerPaykel NS 242 innervator.
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Anaesthesia was induced with propofol 2.5 mg/kg IV
and fentanyl 0.5 µg/kg IV maintained with 1% isoflurane
and 50% nitrous oxide in oxygen. After a stable TOF
response was obtained, group 1 received atracurium 0.5
mg/kg, group 2 received vecuronium 0.1mg/kg over 20
seconds. After induction of anaesthesia, TOF stimulation
of 50 mA was applied to both ulnar nerves at the wrists
every 12 seconds. When twich depression was 90 %(TOF
= 0.1), the tourniquet on the right arm was inflated to a
pressure of 300 mmHg within 5 seconds in both groups.
At the same time, the patient was intubated when
maximum neuromuscular block was attained. The lungs
were ventilated to maintain end-tidal carbondioxide
partial pressure within the range 35-40 mmHg. The TOF
response was recorded up to a twitch recovery of 75% in
both forearms and the tourniquet was deflated.
Meanwhile venous blood samples were obtained from the
right forearm vein.
The following measurements were made:
1) duration between the administration of the
neuromuscular block and a twitch depression of 90%
2) duration between the 90% twithch depression and
75% recovery from neuromuscular block of the perfused
arm,
3) duration between a 90% twitch depression and
75% recovery from neuromuscular block of the arm with
tourniquet,
4) venous blood pH before tourniquet inflation and
before deflation.
Statistical data was presented. Data, between the
arms of the same patients were compared by Student’s t
test and p<0.01 was considered as statistically significant.

Results
There were no differences in age, sex, ASA status,
weight or height between group 1 and group 2 (Table 1).
Peripheral skin temperatures in both arms remained
stable and normal throughout the study and peripheral
venous pH was within physiological limits. The pH of
venous blood samples obtained from the arm with
tourniquet was 7.39+-0.07 in group 1 and 7.36+0.10 in
group 2 (p<0.01). These values for the perfused arm
were 7.41+-0.08 in group 1 and 7.40 + -0.08 in group
2(p>0.01).
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Table 1.

Patient data [number or mean (SD or range)]

atracurium (n=20)
age (yr)
sex (m/f)
weight (kg)

vecuronium (n=20)

51.1
6/14
62.3 +-5.3

49.8
4/16
60.1+-4.2

Onset time of the neuromuscular agents was 4.64+0.70 min in group 1 (atracurium) and 4.82+-0.75 min.
in group 2 (vecuronium). There was no statistical
significance between the 2 groups in time of onset
(p>0.01) (Table 2).
Table 2.

Onset characteristics of atracurium and vecuronium groups.
atracurium M(SD)

vecuronium M(SD)

4.64 (0.70)

4.82(0.75)

Time for 75% recovery
Perfused arm
Tourniquet arm

20.55(2.40)
33.48(3.32)

25.93(2.41)
37.32(3.24)

pH (venous blood)
before tourniquet inflation
before tourniquet deflation

7.41(0.08)
7.39 (0.07)

7.40(0.08)
7.36 (0.10)

Tourniquet inflation time
(TOF=0.1)

In perfused arms, the recovery time of group 2
(25.93+-2.41 min) was greater than that of group 1
(20.55 + -2.40 min). There was a statistically significant
difference between the groups (p<0.01) in the recovery
time of neuromuscular agents. This significance was also
obtained between groups when tourniquet arms were
compared. The recovery time of group 1 was 33.48+3.32 min where as 37.32+-3.24 min in group 2 (Table
2). Recovery of the neuromuscular block in isolated arms
(tourniquet arm) was markedly delayed in comparison
with the control arm (perfused arm) in both groups
(p<0.01) (Figure 1).

Discussion
We found that interruption of arterial blood flow by
tourniquet delays the recovery of the neuromuscular
block. In this respect, atracurium and vecuronium
behaved similarly.
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Changes in the neuromuscular block in the tourniquet
arm.

The tourniquet has been used in the study of recovery
inferences on the mode of action of neuromuscular
blockers (9, 10). In our study, administration of the
neuromuscular blocker was systemic, not in the isolated
arm, and the tourniquet was inflated durign onset, not
during recovery. In other studies the drug was injected in
the isolated forearm or the tourniquet was inflated to
assess recovery after systemic injection of the
neuromuscular blocker (11, 12, 13). The doses of the
neuromuscular blockers were chosen to achieve adequate
neuromuscular block for intubation and were
approximately equipotent. Onset time was 4.64+-0.70
min in the atracurium group and 4.82+-0.75 min in the
vecuronium group, comparable with the findings of the
other studies (12, 13).
The tourniquet was inflated when 90% block was
achieved. We chose not to inflate the tourniquet at a fixed
time after injection, because the amount of drug arriving
at the neuromuscular junction is likely to be different for
both agents, which have different kinetics.
İschaemia of the arm, although very short, might be
suspected to induce local pH modifications or hypoxia,
which would modify the action of neuromuscular
blockers. After inflation of the tourniquet, peripheral

In perfused arms, recovery of the neuromuscular
block in the atracurium group (20.55+2.40 min.)
occurred earlier than in the vecuronium group
(25.93+2.41 min.) as expected because the elimination
half-life of vecuronium is greater then that of atracurium.
Results for the tourniquet arms were also similar in the
atracurium group (33.48+3.32 min.) and in the
vecuronium group (37.32+3.24 min.).
The onset of the action of blockers occurs in two
steps: the time for molecules pass from the injection site
to the muscle, and the time for molecules to redistribute
from non-junctional areas to the neuromuscular junction.
The elimination of the atracurium is dependent on
spontaneus degradation to laudanosine in physiological
conditions (Hoffman degradation) (5, 6). We suggest that
the relative importance of these steps differs between
different blockers. Atracurium block in the isolated
(tourniquet) forearm recovers rapidly, although not
faster than with systemic injection; this is consistant with
a drug that is retained in the biophase despite rapid
plasma metobolism. Vecuronium block in the isolated
forearm is slow to recover, compared with atracurium;
this suggest that a high affinity for the biophase may
contribute to its long duration of action.
The practical result of this study is that neuromuscular
function returns in the isolated arm, which may then
move in response to surgical stimulation, unless other
aspects of the anaesthesia are adequate. This is
potentially serious for the succes of surgery, for example
during microsurgery on the hand. Moreover, the
administration of more neuromuscular blockers is
ineffectual unless the tourniquet is deflated to allow
access to the neuromuscular junction.
We suggest the use of vecuronium in the
microsurgery of the isolated extremities.
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